Umeclidinium/vilanterol

DRUG5 trials

Sponsors

GlaxoSmithKline, Novartis Pharmaceuticals, AstraZeneca, Luis Puente Maestu

Conditions

Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease COPDCopdHeart FailurePulmonary Disease, Chronic Obstructive

Phase 3

A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT01817764

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2013-03-01End: 2013-10-25Updated: 2017-11-08

Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.

CompletedNCT02487498

Novartis PharmaceuticalsChronic Obstructive Pulmonary Disease

Start: 2015-07-27End: 2016-09-06Updated: 2018-04-02

Efficacy and Safety Study of QVA149 in COPD Patients

CompletedNCT02487446

Novartis PharmaceuticalsChronic Obstructive Pulmonary Disease

Start: 2015-07-28End: 2016-09-12Updated: 2017-12-26

Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

CompletedNCT03162055

AstraZenecaChronic Obstructive Pulmonary Disease COPD

Start: 2017-05-25End: 2018-05-04Updated: 2019-05-22

Phase 4

Effect of Dual Bronchodilation With Umeclidinium/Vilanterol on Patients With COPD, Hyperinflation and Heart Failure

RecruitingNCT04522596

Luis Puente MaestuCopd, Heart Failure

Start: 2021-05-21End: 2024-12-31Target: 60Updated: 2024-02-28

Related Papers

Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations

UNC Libraries2021-06-24

A Randomized, Double-Blind, Double-Dummy Study of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Relative to Umeclidinium/Vilanterol Dry Powder Inhaler in COPD.

2019-07-0228 citations

Genetic effects on efficacy to fluticasone propionate/salmeterol treatment in COPD.

2019-06-291 citations

Dual Bronchodilation with Indacaterol Maleate/Glycopyrronium Bromide Compared with Umeclidinium Bromide/Vilanterol in Patients with Moderate-to-Severe COPD: Results from Two Randomized, Controlled, Cross-over Studies.

2017-10-0927 citations

Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations

Respiratory Medicine2015-05-0881 citations